ProMarket

@promarket.bsky.social

Award-winning digital publication of the Stigler Center at the University of Chicago Booth School of Business. RT/Follow ≠ endorsement. #econsky Visit us at https://www.promarket.org/

NEW: Many studies have assumed that United States tariff costs are passed onto consumers. In new research, Vanessa Alviarez, Michele Fioretti, Ken Kikkawa, and Monica Morlacco argue that buyer-seller relationship dynamics allow dominant U.S. importers to instead force higher costs onto exporters.

Market Power Shifts Tariff Costs to Suppliers - ProMarket

Many studies have assumed that United States tariff costs are passed onto consumers. In new research, Vanessa Alviarez, Michele Fioretti, Ken Kikkawa, and Monica Morlacco argue that buyer-seller relationship dynamics allow dominant U.S. importers to instead force higher costs onto exporters.

promarket.org

NEW: Thomas A. Lambert argues that the conservative antitrust program articulated by the antitrust enforcers of the Second Trump administration hardly resembles the conservative antitrust of previous decades. Its divergences will likely end up harming consumers.

New Right vs. Conservative Antitrust - ProMarket

Thomas A. Lambert argues that the conservative antitrust program articulated by the antitrust enforcers of the Second Trump administration hardly resembles the conservative antitrust of previous decades. Its divergences will likely end up harming consumers.

promarket.org

Congratulations to Philippe Aghion on receiving the #NobelPrize in Economics! In 2021, we shared an excerpt of the book he co-authored, “The Power of Creative Destruction,” @harvardpress.bsky.social which explored how #lobbying contributes to increasing the top 1 percent’s share of income.

Barriers to Entry as Another Source of Top Income Inequality - ProMarket

A new book, The Power of Creative Destruction, explores how lobbying contributes to the increase in the top 1 percent’s share of income.

promarket.org

NEW: President Donald Trump has, across two administrations, sought to lower drug prices for Americans, most recently with executive order “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.” Margherita Colangelo explains why his order is unlikely to accomplish its goal.

Will Trump’s Drug-Pricing Order Reduce Prices for Americans? - ProMarket

President Donald Trump has, across two administrations, sought to lower drug prices for Americans, most recently with executive order “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.” Margherita Colangelo explains why his order is unlikely to accomplish its goal.

promarket.org